Is Profound Medical Corp. (PROF) Halal?

NASDAQ Healthcare Canada $225M
✗ NOT HALAL
Confidence: 90/100
Profound Medical Corp. (PROF) is Not Halal under AAOIFI Standard 21. The company's impermissible income ratio of 35.66% exceeds the 5% threshold allowed under AAOIFI. Profound Medical Corp. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 2.7%
/ 30%
28.5%
/ 30%
3.7%
/ 30%
35.66%
/ 5%
✗ NOT HALAL
DJIM 2.7%
/ 33%
28.5%
/ 33%
3.7%
/ 33%
35.66%
/ 5%
✗ NOT HALAL
MSCI 7.3%
/ 33%
78.2%
/ 33%
10.0%
/ 33%
35.66%
/ 5%
✗ NOT HALAL
S&P 2.7%
/ 33%
28.5%
/ 33%
3.7%
/ 33%
35.66%
/ 5%
✗ NOT HALAL
FTSE 7.3%
/ 33%
78.2%
/ 33%
10.0%
/ 50%
35.66%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-1.41
P/B Ratio
3.4
EV/EBITDA
-4.2
EV: $170M
Revenue
$16M
Growth: 43.1%
Beta
0.4
Low volatility
Current Ratio
12.5

Profitability

Gross Margin 70.8%
Operating Margin -123.3%
Net Margin -264.4%
Return on Equity (ROE) -67.1%
Return on Assets (ROA) -34.9%

Cash Flow & Balance Sheet

Operating Cash Flow-$38M
Free Cash Flow-$38M
Total Debt$5M
Debt-to-Equity7.1
Current Ratio12.5
Total Assets$77M

Price & Trading

Last Close$6.30
50-Day MA$6.72
200-Day MA$6.15
Avg Volume234K
Beta0.4
52-Week Range
$3.76
$8.95

About Profound Medical Corp. (PROF)

CEO
Dr. Arun Swarup Menawat MBA, Ph.D.
Employees
162
Sector
Healthcare
Industry
Medical Devices
Country
Canada
Exchange
NASDAQ
Market Cap
$225M
Currency
USD

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Profound Medical Corp. (PROF) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Profound Medical Corp. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Profound Medical Corp.'s debt ratio?

Profound Medical Corp.'s debt ratio is 2.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 7.3%.

What are Profound Medical Corp.'s key financial metrics?

Profound Medical Corp. has a market capitalization of $225M, and revenue of $16M. The company maintains a gross margin of 70.8% and a net margin of -264.4%. Return on equity stands at -67.1%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.